Episode 153: Roflumilast when you add it on for COPD does it add up?
In episode 153, James and Mike attempt to breath life into a new agent for COPD called roflumilast. Unfortunately, by the end of the podcast we find out that the effect of this agent doesn’t leave Mike and James breathless but unfortunately it will leave our COPD patients that way.
Show notes
1)Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
2) Is roflumilast (Daxas®) beneficial as an add-on therapy in the management of COPD?
3) Tiotropium or salmeterol for COPD?
N Engl J Med 2011;364:1093-1103
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!
